Story thread · 2 reports / 2 sources

Novonesis beats expectations and raises guidance

cphpost.dk · 6h · first reportShare

Danish biotech group Novonesis performed better than expected in the second quarter and has raised its full-year expectations. As a result, it upgraded its organic revenue growth outlook to 7–8 percent from the previous 5–7 percent. The company reported revenue of 1,116.2 million euros, slightly exceeding analyst expectations of 1,100.9 million euros. Growth in the […]